Artal Group S.A. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 118 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.92 and the average weighting 1.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$2,726,000
-49.2%
100,000
-50.0%
0.11%
-49.8%
Q2 2019$5,370,000
-53.6%
200,000
-50.0%
0.22%
-54.0%
Q1 2019$11,564,000
+7.4%
400,0000.0%0.47%
+18.3%
Q4 2018$10,772,000400,0000.40%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders